Skip to main content

Market Overview

13
Articles

SciSparc

September 22, 2022 9:30 AM
TEL AVIV, Israel, Sept. 22, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC) (“Company” or “SciSparc”), a specialty clini ...
August 25, 2022 7:37 AM
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment TEL AVIV, Israel, Aug. 24, 2022 (GLOBE NEWSWIRE) - ...
August 12, 2022 9:17 AM
Patent extends protection for SciSparc’s novel compounds and methods already granted in the U.S., Austra ...
June 29, 2022 8:38 AM
TEL AVIV, Israel, June 29, 2022 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC) (the "Company" or "SciSparc"), a specialty, clinical-stage pharmaceutical ...
June 23, 2022 11:34 AM
The Soroka University Ethics Committee Approval Received to Conduct a Clinical trial with SciSparc’s Proprietary SCI-210 Treatment TEL AVIV, Isr ...
June 15, 2022 8:48 AM
JV Targets Potential Drugs for Cancers and Infectious Diseases  TEL AVIV, Israel, June 15, 2022 /PRNewswire/ -- SciSparc Ltd. (Nasdaq: SPRC) (the ...
June 07, 2022 8:36 AM
SciSparc and Clearmind recently announced the filing of a patent application related to treating cocaine addiction TEL AVIV, Israel, June 7, 2022 /PRN ...
June 02, 2022 10:22 AM
No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a s ...
May 31, 2022 9:24 AM
SciSparc will use its SCI-160 technology platform for treating pain in combination with Polyrizons' Trap and TargetTM technology T ...
May 26, 2022 8:47 AM
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in Germany and Israel  TEL AVIV, Israel, May 26, 2022 / ...
May 24, 2022 8:40 AM
Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption TEL AVIV, Israel, May 24, 2 ...
May 10, 2022 8:54 AM
Preclinical study results demonstrated the combination of SciSparc's CannAmide™ with Clearmind's MEAI has the potential to reduce alcohol c ...
May 02, 2022 8:34 AM
TEL AVIV, Israel, May 2, 2022 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the developm ...